Prota cracks $20m raising for its allergy treatment
MELBOURNE: Australian biotech Prota Therapeutics is chasing $20 million to prepare Phase 3 testing for
MELBOURNE: Australian biotech Prota Therapeutics is chasing $20 million to prepare Phase 3 testing for
FEATURED
New elderly hub to be ‘exemplar’ of care for future
Best nursing home design for Global Awards shortlisted
Health app start-ups race raises concerns with GPs
Seniors housing operators must embrace healthcare-based models
Investor survey and trends report into seniors living & care published
Elderly sisters and laypeople share housing and community in béguinage
INNOVATION
